The B2MC team has developed know-how in bio-organic chemistry (synthesis of biomolecules). With regard to the pharmacological evaluation of target compounds (cancer and chemoresistance), B2MC relies on 2 special partners: first the Institut de Biologie et Chimie des Protéines [Institute of the biology and chemistry of proteins - IBCP] of Lyon and second, the Institut für Pharmazeutische und Medizinische Chemie [Institute of medicinal and pharmaceutical chemistry - IPMC] of Düsseldorf...
News